We thank Dietze and colleagues for their letter and offer the following responses.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Degenhardt L, Larney S, Chan G, et al. Estimating the number of regular and dependent methamphetamine users in Australia. Med J Aust 2016; 204: 153. <MJA full text>
- 2. McKetin R, McLaren J, Kelly E, et al. Estimating the number of regular and dependent methamphetamine users in Australia. Technical Report No. 230. Sydney: National Drug and Alcohol Research Centre; 2005.
- 3. Australian Institute of Health and Welfare. Alcohol and other drug treatment services in Australia 2014–15 (AIHW Cat. No. HSE 173; Drug Treatment Series No. 27). Canberra: AIHW; 2016.
- 4. Sara GE, Burgess PM, Harris MG, et al. Stimulant use and stimulant use disorders in Australia: findings from the national survey of mental health and wellbeing. Med J Aust 2011; 195: 607-609. <MJA full text>
- 5. Australian Institute of Health and Welfare. Trends in methylamphetamine availability, use and treatment: 2003–04 to 2013–14 (AIHW Cat. No. HSE 165; Drug Treatment Series No. 26). Canberra: AIHW; 2015.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Degenhardt is supported by a National Health and Medical Research Council Principal Research Fellowship (no. 1041472). The National Drug and Alcohol Research Centre at the University of New South Wales and the National Drug Research Institute at Curtin University are supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. The Centre for Youth Substance Abuse Research at the University of Queensland receives core funding from the Graeme Wood Foundation.